VERTEX PHARMACEUTICALS INC
Quarter 2026Q2 · CUSIP 92532F100
Size · Holdings
$12.8B
#70 · 13 Holders
Total market value held across tracked managers.
Force · Net Flow
$1.4B
#160 · estimated
This quarter's net buying (est. Σ share change × current price).
Consensus · Breadth
+0
6▲ 6▼ · 2 New
Net-buying groups minus net-selling groups (related filers count once).
Who's adding
norges+$1.5B
aqr+$220M
millennium+$189M
rentec+$159M
citadel+$128M
marshall_wace+$110M
Who's trimming
point72-$782K
gotham-$944K
bridgewater-$1M
fisher-$3M
two_sigma-$46M
capital_group-$812M
Compiled from public SEC 13F-HR filings for a sample of 64 tracked institutions — NOT the whole market. 13F covers long US-listed equity only (no shorts, derivatives, or non-US holdings) and lags ~45 days. Net flow is estimated from share changes × current-quarter price. Institutional-behavior observation, not investment advice.